Postgraduate Course in Medical Oncology
National Belgian Program
(2011 - 2012)

EORTC Headquarters
Henri Tagnon Meeting Room (2nd Floor)
Avenue Emmanuel Mounier, 83 - B11
B - 1200 Brussels


COURSES REGISTRATION FORM

PARTICIPANT'S DETAILS

THESE COURSES ARE NOT OPEN TO REPRESENTATIVES FROM PHARMACEUTICAL COMPANIES

Title   Department
Last Name   Function
First Name   City
Institution / Company   Email

 

COURSES
Saturday 9.00 AM - 12.00 AM

1 October 2011

SESSION 1: Clinical Trials (Chair: Patrick Schöffski)
- Design of clinical trials and endpoints (Jan Bogaerts)
- Analysis and reporting (Laurence Collette):
Discussion of example manuscript and presentation of results

- Methods for evaluation of response (Patrick Schöffski)
- Integrating biomarkers in early clinical trials (Stefan Michiels)
Handout materials: GCP documents

Registration is closed
19 November 2011

SESSION 2: Molecular Biology for Clinicians
Chair: Martine Piccart
09.00 - 09.40: Introduction to new technologies for dissecting the complexity of cancer (Ch. Desmedt - Bordet)
09.40 - 10.20: Signalling pathways: What the oncologist should know (Sh. Loi - Bordet)
10.20 - 10.40: Break
10.40 - 11.20:  Angiogenesis: Understanding the key targets and the resistance mechanisms (K. De Bock - KUL)
11.20 - 12.00:  Implementation of new technologies in a cancer center in order to improve patient treatment tailoring (F. André - IGR)

Registration is closed
10 December 2011

SESSION 3: Reading, Writing and Presenting
Chair: Pol Specenier
Presenting - J. Vermorken
Writing - L. Rowett
Critical reading of papers - C. Fortpied
Use of internet tools - P. Meijnders

Registration is closed
14 January 2012

SESSION 4: Communications Skills
Chair: Simon Van Belle
Communication with the cancer patient and his/her family - D. Razavi
Interprofessional communication - TBC
Issues in the communication with children of cancer patients - L. Dillen
Issues in the communication with palliative patients - W. Schrauwen
Issues in the communication from the pharmaceutical industry to the medical community - D. Van den Wyngaert

Registration is available
since 16 December 2011
4 February 2012

SESSION 5: Early Breast Cancer
Chairs: Guy Jerusalem & Vincent Remouchamps
DCIS indications for adjuvant treatment - N. Bijker
T1, T2N0-1 surgery and reconstructive procedures - R. Deraemaecker & F. Liebens
Prognostic factors/pathology - R. Salgado
Radiotherapy - V. Remouchamps
Adjuvant Systemic Therapy in 2012 - A. Awada 

Registration is available
since 6 January 2012
17 March 2012

SESSION 6: Melanoma & Sarcoma: Medical Treatments
Chairs: Jean-Pascal Machiels & Xavier Geets
Melanoma surgery and adjuvant treatment and limb perfusion - C. Verhoef
Vaccination studies: present and future - J.F. Baurain
Soft tissue sarcoma: principles of surgery - C. Verhoef
Systematic treatment of soft tissue sarcoma - H. Dumez
Sarcoma: principles of adjuvant radiotherapy - X. Geets

Registration is available
since 17 February 2012
28 April 2012

SESSION 7: Locoregional Lung Cancer
Chair: Jacques De Grève
Implication of pathology and genomics in treatment decision - P. Pauwels
Implications of the new TNM in treatment decision - T. Berghmans
Mediastinal staging and indications and techniques of surgery - H. Decaluwé
Combined modalities - P. Van Houtte
Targeted therapies and new experimental approaches - J. De Grève

Registration will be available
on 30 March 2012

Important notes
- For logistic purposes, registration for these courses is mandatory
- Registration is free of charge
- Registration is limited to 70 participants
-
All participants have to sign the attendance list (which will be available in the meeting room)
- Should you have to cancel your participation, please do it by the Thursday before the course
- Cancellation of registration has to be faxed or e-mailed to the EORTC Communications Office (see here below)
- The language of the course is English

EORTC Communications Office - Fax: +32 2 772 62 33 - E-mail: communications@eortc.be